Summary
The effects of dopexamine on the renal circulation have been examined to show whether any augmentation of renal blood flow (RBF) was secondary to the effect of the drug on cardiac output (CO) or whether it had any additional direct renal vasodilator activity.
Eight male patients with mild to moderate hypertension, who were undergoing renal vein catheterization for renin estimation, were studied. Dose related increments in RBF (baseline (B)=504 ml·min−1; after treatment (D)=605 ml·min−1), CO (B=5.9 l·min−1; D=6.7 l·min−1), heart rate (B=77 beats/min; D=100 beats/min) and systolic blood pressure (B=143 mmHg; D=166 mmHg) were observed on administration of dopexamine 3 µg·kg−1·min−1, with insignificant changes in diastolic blood pressure (B=84.4 mmHg; D=90 mmHg) and total peripheral resistance (B=17.85; D=17.25 Units). There was a slight but significant reduction in renal vascular resistance (B=20.59, D=18.75). The ratio of RBF to CO (%) confirmed that the increase in RBF due to dopexamine hydrochloride was greater that attributable to the increase in CO or perfusion pressure alone (RBF/CO B=8.5%, D=9%), consistent with selective renal vasodilation. The fall in renin activity and lack of systemic vasodilatation suggest that this was a DA1-receptor mediated effect.
Similar content being viewed by others
References
Brown RA, Dixon J, Farmer JB, Hall JL, Humphries RL, Ince F, O'Connor SE, Simpson WT, Smith GW (1985) Dopexamine: A novel agonist at peripheral dopamine receptors and B2-adrenoceptors. Br J Pharmacol 85: 599–608
Dawson JR, Thompson DS, Signy M, Juul SM, Turnbull P, Jenkins BS, Webb-Peploe MM (1985) Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure. Br Heart J 54: 313–320
Brown RA, Farmer JB, Hall TC, Humphries RG, O'Connor SE, Smith GW (1985) The effects of dopamine on the cardiovascular system of the dog. Br J Pharmacol 85: 609–619
Magrini F, Guo-Quing L (1982) A critical improvement of the local thermodilution method for measuring renal blood flow in man. Cardiovasc Res 16: 350–354
Magrini F, Ibrahim MM, Tarazi RL (1976) Abnormalities of supine haemodynamics in idiopathic orthostatic hypotension. Cardiology 61 [Suppl 1]: 125–130
Guazzi M, Olivari MT, Polese A, Fiorentini C, Magrini F (1977) Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther 22: 528–532
Pitts RF (1974) Renal circulation chapter 9. In: Pitts RF (ed) Physiology of the kidney and body fluids, 3rd edn. Year Book Medical Publ, Chicago, pp 158–177
De Leeuw P, Schalekamp MA, Birkenhäger WH (1983) The renal circulation in hypertension. In: Robertson JIS (ed) Handbook of hypertension, vol I. Clinical aspects of essential hypertension. Elsevier Science Publ, Amsterdam, pp 202–215
Lee MR (1982) Dopamine and the kidney. Clin Sci 62: 439–448
Author information
Authors and Affiliations
Additional information
European Exchange Senior House Office supported by EEC fellowship 1985 Ospedale Maggiore, Milano, Italy
Rights and permissions
About this article
Cite this article
Magrini, F., Foulds, R., Roberts, N. et al. Human renovascular effects of dopexamine hydrochloride: A novel agonist of peripheral dopamine and beta2-adreno-receptors. Eur J Clin Pharmacol 32, 1–4 (1987). https://doi.org/10.1007/BF00609949
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609949